Ani Pharmaceuticals (ANIP) EBIT Margin Growth (1y) (2012 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) EBIT Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -1,647.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -634.00 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -1,576.00 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 93.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 840.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -12,485.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 864.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -258.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 3,802.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 864.00 |
| Mar 31, 2026 | 309.00 |
| Dec 31, 2025 | 1,637.00 |
| Sep 30, 2025 | 2,974.00 |
| Jun 30, 2025 | 283.00 |
| Mar 31, 2025 | -149.00 |
| Dec 31, 2024 | -741.00 |
| Sep 30, 2024 | -2,745.00 |
| Jun 30, 2024 | -690.00 |
| Mar 31, 2024 | 551.00 |
| Dec 31, 2023 | 318.00 |
| Sep 30, 2023 | 1,957.00 |
| Jun 30, 2023 | 2,813.00 |
| Mar 31, 2023 | 3,904.00 |
| Dec 31, 2022 | 4,087.00 |
| Sep 30, 2022 | 88.00 |
| Jun 30, 2022 | 1,450.00 |
| Mar 31, 2022 | -3,536.00 |
| Dec 31, 2021 | -3,951.00 |
| Sep 30, 2021 | -1,213.00 |